Progress of mesenchymal stem cell therapy for neural and retinal diseases - Wikidata - wikimedia - TriplyDB

Progress of mesenchymal stem cell therapy for neural and retinal diseases

Progress of mesenchymal stem cell therapy for neural and retinal diseases

http://www.wikidata.org/entity/Q27015716

about

Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century Current perspectives in mesenchymal stem cell therapies for osteoarthritis Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy Mesenchymal stem cells attenuate hydrogen peroxide-induced oxidative stress and enhance neuroprotective effects in retinal ganglion cells.Compound anisodine affects the proliferation and calcium overload of hypoxia-induced rat retinal progenitor cells and brain neural stem cells via the p-ERK1/2/HIF-1α/VEGF pathway.Renal stem cell reprogramming: Prospects in regenerative medicine.Encapsulating non-human primate multipotent stromal cells in alginate via high voltage for cell-based therapies and cryopreservation.Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a preliminary report.Human Dermal Fibroblasts Demonstrate Positive Immunostaining for Neuron- and Glia- Specific Proteins.Spinal cord injury in rats treated using bone marrow mesenchymal stem-cell transplantation Polydatin Protects Bone Marrow Stem Cells against Oxidative Injury: Involvement of Nrf 2/ARE Pathways.Reprogramming somatic cells to cells with neuronal characteristics by defined medium both in vitro and in vivo.Effects of Serial Passage on the Characteristics and Cardiac and Neural Differentiation of Human Umbilical Cord Wharton's Jelly-Derived Mesenchymal Stem Cells.Exosomes as a Nanodelivery System: a Key to the Future of Neuromedicine?Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models.Gender difference in the neuroprotective effect of rat bone marrow mesenchymal cells against hypoxia-induced apoptosis of retinal ganglion cells.Microvesicles from brain-extract-treated mesenchymal stem cells improve neurological functions in a rat model of ischemic stroke.Peripheral Inflammatory Markers Contributing to Comorbidities in Autism.Experimental Study of the Biological Properties of Human Embryonic Stem Cell-Derived Retinal Progenitor Cells Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage.Metabolic restructuring and cell fate conversion.Current focus of stem cell application in retinal repair.Present and New Treatment Strategies in the Management of Glaucoma.Infusion of umbilical cord mesenchymal stem cells alleviates symptoms of ankylosing spondylitis.Management of glaucoma as a neurodegenerative disease.Extrinsic and Intrinsic Mechanisms by Which Mesenchymal Stem Cells Suppress the Immune System.Human Embryonic Stem Cells in the Treatment of Autism: A Case Series.Remyelination improvement after neurotrophic factors secreting cells transplantation in rat spinal cord injury.Neuoroprotective efficacies by KUS121, a VCP modulator, on animal models of retinal degeneration.Immunophenotypic characterization of ovine mesenchymal stem cells.Scalable Expansion of Human Pluripotent Stem Cell-Derived Neural Progenitors in Stirred Suspension Bioreactor Under Xeno-free Condition.Recent Updates on Treatment of Ocular Microbial Infections by Stem Cell Therapy: A Review.Assessment of Central Visual Function in Patients with Retinitis Pigmentosa.Branched chain amino acids attenuate major pathologies in mouse models of retinal degeneration and glaucoma.Tanshinone IIA promotes the differentiation of bone marrow mesenchymal stem cells into neuronal-like cells in a spinal cord injury model.Stem cell therapy for retinal ganglion cell degeneration

P2860

Q26795447-791592C8-7268-45B8-8887-719622C524B0 Q26865832-5D0E69B4-2639-4CAB-A02E-A26205978F6F Q28072497-E53BC78E-A3BB-4AFD-95C9-12F561E4C2AF Q29994669-00BA0F50-8989-46B0-9B8E-B1C51E0EFF65 Q32186021-CAAB96BB-05D2-46E4-A12B-351143EFA71C Q33846469-D741B05F-564E-4C91-A45A-AC6FD0A1AB4F Q34232871-62C6ED9F-E42E-42F3-8B0B-A0DEE4CF7132 Q35279648-8FCB2061-C6C9-4848-AC5E-1E7910F6912B Q35838003-2F12759F-21D4-4247-B1A7-F5CD4914C1A1 Q35871811-41AB2235-174F-424B-8C26-3C2D9992424A Q35959608-85346346-8D61-4F49-A232-E9F6ABFC7409 Q36386720-B747D912-203F-469D-98A9-D26146ABE8FF Q36416719-E7155285-C351-4625-B0E5-35DB73C0D269 Q36424207-798A456A-7530-4482-96FD-C5CD0CD94A31 Q36577074-ACA5E0A6-EBEF-45ED-AB98-372B2AEFC3A8 Q36939755-398EC9C3-38B1-4B09-B331-821861BD2693 Q36996649-82772A88-A676-4EF8-83F5-606123EED1A9 Q37243413-12B5F672-9055-48E3-BBBD-CC96D69ACB44 Q37542184-FD2936D7-75F9-4A32-8745-1E3B23BD5647 Q37638099-896F5C83-820C-4BA3-8DF2-C504FD4C0C11 Q37677012-47D97ADF-F76A-4DCB-BC80-3819945FAB65 Q38317505-C7C6AC11-B37A-40BE-A365-5EEB601B49DB Q38443625-D8EA21A1-D3AA-496E-ABBD-167E109DB5BA Q38526185-E721D162-87C1-4A1C-A829-22E59B983F3D Q38646267-42871FC0-A3B9-49C7-8EF0-0078E793AE47 Q38679475-190B21A8-C810-4EC7-AD24-29F8C54BB3D5 Q38709705-2A566631-F98F-433E-9AEB-D047E19955CC Q40171550-B73F1951-79D2-4235-833F-CA52F4AB3D40 Q41850476-C797A821-2B9B-4D23-BF38-B578BC493FDC Q41976417-1262545E-9BEF-4AF5-B559-A6F0088B6FD4 Q48827577-9B723BF1-9FD3-41A9-892A-4A5F11C8E8C6 Q48913622-C1B4E979-81D8-456B-B4A9-291F3DDE6B85 Q50042214-581A7B3F-318B-4FFA-B651-DB09A4FF9C46 Q54956395-24973CAB-32F1-486F-B7A2-06136FC2BAF2 Q55402017-ABA3A938-7EDA-4CCC-875B-20B813616078 Q55640649-0C916AF0-CE0B-4418-BFDE-C43522B2322B Q58805404-E97DFBBD-5BFC-460A-B936-D4F23967CE4A

P2860

Progress of mesenchymal stem cell therapy for neural and retinal diseases

http://www.wikidata.org/entity/Q27015716

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Progress of mesenchymal stem cell therapy for neural and retinal diseases

@ast

Progress of mesenchymal stem cell therapy for neural and retinal diseases

@en

Progress of mesenchymal stem cell therapy for neural and retinal diseases

@nl

type

label

Progress of mesenchymal stem cell therapy for neural and retinal diseases

@ast

Progress of mesenchymal stem cell therapy for neural and retinal diseases

@en

Progress of mesenchymal stem cell therapy for neural and retinal diseases

@nl

prefLabel

Progress of mesenchymal stem cell therapy for neural and retinal diseases

@ast

Progress of mesenchymal stem cell therapy for neural and retinal diseases

@en

Progress of mesenchymal stem cell therapy for neural and retinal diseases

@nl

P1433

Q27015716-CD976688-4C80-4EFB-9337-3E4824A793C0

P1476

Q27015716-A47225B6-874B-4E19-98CB-C4633921A9C4

P2093

Q27015716-3579D11B-383E-47C8-8E33-D97B55737210

Q27015716-3D07B87C-9298-42F9-A256-D81BBAFAB4D8

Q27015716-EE3BC333-635D-49AC-AE93-99C497E6E2A0

P2860

Q27015716-00E6E8E2-23FC-4170-8311-CAAF93AF9487

Q27015716-0A0D3C70-3F60-4032-96CA-337885025558

Q27015716-0D02FFAB-BB30-472B-B343-BDA50CCC8A3D

Q27015716-1450A97A-47B3-44D2-B4A3-816C70E9D022

Q27015716-170B2E3A-4443-44E8-8D77-19B2FB9C46FE

Q27015716-17BE8CA2-C7B1-4A16-AAEA-5E0077EF30AC

Q27015716-18868563-0B0E-497F-A624-1716F7452A31

Q27015716-1C36C38C-08B3-406E-BF89-DB1C6F8F7BAF

Q27015716-2266C2EF-1EA2-4EC8-BCFF-126FED337FE4

Q27015716-22CC9CBB-5152-429D-A4DB-24FA6B114B89

P304

Q27015716-6FD04B8B-5020-477B-9B93-C45BE251108C

P31

Q27015716-07A1F45D-ECBA-4DD3-953A-AA91A233FE55

P3181

Q27015716-381149BF-7D01-4F44-B907-143B848EDC2A

P356

Q27015716-84D16A1A-1500-49CA-A27F-7BFA790E1D58

P407

Q27015716-8942B541-8849-4F2D-9CDE-1E0C4177F19C

P433

Q27015716-F9426618-028D-482D-B6BC-43DC59AE0138

P478

Q27015716-177C3566-220D-478C-9DAE-C244C000A97E

P50

Q27015716-DFE354FC-35AC-40B0-8D95-247C26FBF94B

P577

Q27015716-7A16AEED-BF0A-4480-A0B4-ABA4EBD7F499

P5875

Q27015716-FC2239BD-7C9C-42BB-90DA-211D2F67B44E

P698

Q27015716-BE56C54D-19BF-4C78-A696-2BF781966EC6

P932

Q27015716-52AD4BD9-3E0B-419F-B4DE-BBED52EF5741

P3181

P356

P1433

World Journal of Stem Cells

P1476

Progress of mesenchymal stem cell therapy for neural and retinal diseases

@en

P2093

Daniel Pelaez

http://www.w3.org/2001/XMLSchema#string

Herman S Cheung

http://www.w3.org/2001/XMLSchema#string

Veronica R Fortino

http://www.w3.org/2001/XMLSchema#string

P2860

Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?

Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

Stem cell therapy for autism

Multilineage potential of adult human mesenchymal stem cells

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

Multiple sclerosis

Retinitis pigmentosa

P304

111-119

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1925947

http://www.w3.org/2001/XMLSchema#string

P356

10.4252/WJSC.V6.I2.111

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261923483

http://www.w3.org/2001/XMLSchema#string

P698

24772238

http://www.w3.org/2001/XMLSchema#string

P932

3999769

http://www.w3.org/2001/XMLSchema#string